// App-Quantinova.ai

EP291 : Cabergoline treatment: The ethics around side effects

Researchers

Presenter

  • Risheka Ratnasabapathy

Principal Investigators

  • Bijal Patel

  • Ambreen Qayum

  • Shamaila Zaman

  • Preeshila Behary

  • Karim Meeran

  • Niamh Martin

Medical Centers

  • Imperial College NHS Healthcare Trust, Department of Endocrinology, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Urology

Disease

  • Male Sexual Dysfunction

  • Pituitary adenomas

  • Prolactin-secreting pituitary adenoma

  • Epilepsy

Biomarkers

  • Adrenocorticotropic hormone

  • Prolactin

  • Cortisol

  • Follicle-stimulating hormone

  • Sex hormone binding globulin

Drug/Treatment

  • Prednisolone

  • Cabergoline

  • Dopamine hydrochloride

  • Midazolam

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved